The government has once again put its foot down and opposed to the request made by the pharmaceutical industry and the National Assembly to postpone drug price cuts applied under the Price-Volume Agreement (PVA) system until the exchange rate and prices stabilize.

The government also added that it is working on an improvement plan for the drug pricing system that includes a preferential drug pricing policy for homegrown new drugs or preferential drug prices for drugs using domestic APIs.

On the 1st, the Ministry of Health and Welfare announced so through the ‘Report on the 2022 National Audit Results Correction and Processing Requirements'.

The MOHW again expressed